Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
about
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsEpigenetics in liver diseaseTargeting CSC-related miRNAs for cancer therapy by natural agentsImplications of biomarkers in human hepatocellular carcinoma pathogenesis and therapyEpigenetic regulation of hematopoietic stem cell agingEpigenetics in liver disease: from biology to therapeuticsEZH2 in Bladder Cancer, a Promising Therapeutic TargetEpigenetic regulation in hepatocellular carcinoma requires long noncoding RNAsThe methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regenerationEpigenetic Alterations in Parathyroid CancersLarge oncosomes mediate intercellular transfer of functional microRNA.Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBMFocal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449amicroRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancerMicroRNAs associated with HBV infection and HBV-related HCC.miRNAs and cancer: an epigenetics view.Complex interactions between microRNAs and hepatitis B/C viruses.Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferationEpigenetic alteration and microRNA dysregulation in cancerPromotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseEZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human CancersPolycomb-mediated loss of microRNA let-7c determines inflammatory macrophage polarization via PAK1-dependent NF-κB pathway.EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.Integrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.PRC2 regulates RNA polymerase III transcribed non-translated RNA gene transcription through EZH2 and SUZ12 interaction with TFIIIC complex.Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transitionEnhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors.LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancerGenomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical developmentTumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular CarcinomaGenetic alteration and misexpression of Polycomb group genes in hepatocellular carcinoma.Function and clinical potential of microRNAs in hepatocellular carcinoma.TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene ExpressionFunctional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
P2860
Q26745338-CFEC6DBB-28A8-42E0-B746-CBC6C1049744Q26773183-4452DD78-6859-4C3E-831D-41FF29799313Q26849263-7140C413-5649-42AA-BB2A-20CF27BDA4CEQ27003230-07580F3F-203E-4FCD-AA21-ADD29BA77F81Q27005850-0F1F34BA-07CF-490C-BA70-B3F5F3D00516Q27026054-F4E4847A-128A-4275-97A7-9C26C24BC5D9Q28079271-B4AD4303-8C58-4048-A2AD-D0EF1C80508CQ28082054-843F5ECD-A923-4917-A121-63A5D8BCCE95Q28084553-742DA4C9-393C-4E00-AE57-D40F6A0587D9Q28509576-D657013D-A314-4B58-8DF5-D0C2EFB4E2F1Q30398206-8AF69F0E-751A-4EC5-AB78-2CAAE2187A3DQ30570006-1E9C5FA0-FB4F-43FB-9ED0-24023785DA05Q33648797-0A35F3CE-9708-4784-A092-149B565C6755Q33652164-C76DC005-FDD8-4E4C-96EF-17C41B0F2922Q33688606-026C2639-B87C-4749-9BB5-B3463DE3DD92Q33784290-DDA23BC1-50E3-4231-AB59-7E5DC2827BBCQ34284404-706C7FE8-07F5-4CE4-805F-03BA9B982C8CQ34286618-852F40B7-8DC9-4C66-B4DE-FC7B93C0EADFQ34302987-80496608-09CB-4934-868D-173225F04993Q34317380-6CF9BAD2-B232-462A-B9EC-77E1ADC44F2AQ34392645-D67F5FE5-C924-469B-B5E1-B90CA9D31DF5Q34451033-89D3E369-6924-4763-85A4-6C485E95361AQ34797908-1D8311F3-8A34-4C00-8CBC-DE6CDBE82198Q34924167-51C75058-A606-4594-99DE-82727A96FF95Q34956954-86EB8BE7-FE1D-418E-B44B-BB42D3BF6C8EQ35020627-E6048CAA-0A2F-4B2D-93DD-7A8C4DBB7EDCQ35715931-3E6FE459-E284-4243-89A2-58C23A140F7CQ35787278-BA72E1C1-A673-4BD7-989F-DA6A3768BFECQ35885921-6DA30968-3396-4B7E-B283-B3CF2A8C29DCQ35959917-C099E3CD-EDA6-4609-B0EC-4B38F8380008Q36179615-7ABC7C16-95FE-45BD-8FDD-3DA76B1FD3E6Q36217858-DDEC6961-1F2E-4D70-BE74-3870BF13A5BAQ36293805-813905A4-8690-40DA-A4B0-6DE410894CB5Q36299617-32B9FEF6-1092-40C5-94F9-4CEC85F474AEQ36301347-934186CB-C753-4166-8000-DD12A1CEEA44Q36309367-644BDCD8-8C68-4832-920F-5149BC4B9E50Q36336198-B38A6D6B-C007-48C0-A9BC-2C117F93FBD4Q36439839-AE87A6F0-CD80-4154-8AA9-F7FB6A34A738Q36540471-609D2FB2-918C-4913-A5B8-1045965A14A3Q36545734-ED327CF1-04F6-4E12-A74A-D8DDC2B250AB
P2860
Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@ast
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@en
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@nl
type
label
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@ast
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@en
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@nl
prefLabel
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@ast
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@en
Enhancer of zeste homolog 2 ep ...... omote liver cancer metastasis.
@nl
P2093
P356
P1433
P1476
Enhancer of zeste homolog 2 ep ...... romote liver cancer metastasis
@en
P2093
Carmen Chak-Lui Wong
Chun-Ming Wong
Dorothy Ngo-Yin Fan
Felice Hoching Tsang
Joyce Man-Fong Lee
Sandy Leung-Kuen Au
P304
P356
10.1002/HEP.25679
P407
P50
P577
2012-06-11T00:00:00Z